news > tag > north-america-en

Tumor-Killing Targeted Radiation PRRT Approved by U.S. FDA

David T. Drummond ⎜Feb 14, 2018 ⎜ Industry

The first Peptide Receptor Radionuclide Therapy (PRRT) has received FDA approval. Lutetium 177 DOTA-TATE (Lu 177), a type of PRRT, is now approved for the treatment of somatostatin-receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut tumors in adults.

FDA approval of PRRT using Lu-177 will allow more eligible U.S. patients to receive this “life extending” treatment. Lu-177 is manufactured by Advanced Accelerator Applications (AAA), a Novartis company. Prior to the FDA approval, PRRT with Lu-177 was only available in a limited number of American treatment centers as part of an expanded access program or through a clinical trial.

Click here to see full news release.

Tags:

Exhibits at Nuclear Medicine Congress (2016)

David T. Drummond ⎜Jun 1, 2016 ⎜ Industry

The Society of Nuclear Medicine and Molecular Imaging opens today in Baltimore and isoSolutions is exhibiting and promoting its products and services.

isoSolutions provides a one-stop shopping service as well as technical support worldwide for nuclear medicine applications including: Radiochemicals, Stable isotopes, Labeled compounds, Sealed sources, Synthesizers and Peptides. A package of products and services for diagnostic or therapeutic radiolabeling applications includes a Ga-68 Generator, Lu-177, Y-90, a Re-188 Generator, I-131, I-125, O-18 Water and cyclotron products. These products are complemented by an automated labeling module for development work or preprogrammed syntheses.

The offices of isoSolutions have a global reach:

Americas: Vancouver and Montreal;

local telephone contact in Argentina, Chile, Mexico, Brazil

Europe: Budapest; Brussels

Asia: Shanghai

Middle East and Africa: Beirut

The suppliers represented by isoSolutions reliably provide high-quality products: iThemba, Trasis, IRE, Polatom, Nukem, Radqual, Izotop, Isotopia and ABT.

David Drummond, Managing Director of isoSolutions, stated: “We look forward to welcoming our customers and displaying our capabilities at our exhibit at the SNMMI congress in Baltimore.”

About isoSolutions Marketing & Management Inc.

More information on the company can be found at isoSolutions.

Tags:

Exhibits at Nuclear Medicine Congress (2015)

David T. Drummond ⎜Jul 7, 2015 ⎜ Industry

The Society of Nuclear Medicine and Molecular Imaging opens today in Baltimore and isoSolutions is exhibiting and promoting its products and services.

isoSolutions provides a one-stop shopping service as well as technical support worldwide for nuclear medicine applications including: Radiochemicals, Stable isotopes, Labeled compounds, Sealed sources, Synthesizers and Peptides. A package of products and services for diagnostic or therapeutic radiolabeling applications includes a Ga-68 Generator, Lu-177, Y-90, a Re-188 Generator, I-131, I-125, O-18 Water and cyclotron products. These products are complemented by an automated labeling module for development work or preprogrammed syntheses.

The offices of isoSolutions have a global reach:

Americas: Vancouver and Montreal; local telephone contact in Argentina, Chile, Mexico, Brazil

Europe: Budapest; Brussels

Asia: Shanghai

Middle East and Africa: Beirut

The suppliers represented by isoSolutions reliably provide high-quality products: iThemba, Trasis, IRE, Polatom, Nukem, Radqual, Izotop, Isotopia and ABT.

David Drummond, Managing Director of isoSolutions, stated: “We look forward to welcoming our customers and displaying our capabilities at our exhibit at the SNMMI congress in Baltimore.”

About isoSolutions Marketing & Management Inc.

More information on the company can be found at isoSolutions.

Tags:

isoSolutions Adds Sales & Marketing Manager for North America

David T. Drummond ⎜Nov 29, 2014 ⎜ Industry

isoSolutions has expanded its sales and marketing resources by adding Ms. Patricia Acton, who will be responsible for the Canadian and United States markets. The sales and marketing team is now assigned as follows:

• Patricia Acton (Canada, United States)
• Marvin Calderón (Latin America)
• Hans Peng (Asia)
• Carlo Chemaly (Middle East, Europe, Africa)

The marketing representatives enable the customers to deal with isoSolutions in their native languages (English, Spanish, Portuguese, Mandarin, French and Arabic) The new organization is designed to provide the best solutions for the clients of the company.

Pat Acton brings to the team experience in business analysis and problem solving, with particular emphasis on long term customer relations and assistance. She is an asset to our team which is already strong in providing unique solutions to the nuclear medicine needs of the isoSolutions customer base.

David Drummond, Managing Director of isoSolutions, stated: “We are pleased to welcome Patricia to our team. We now have resources in place to respond to the needs of our customers in each of our major territories – North America, Latin America, Asia and the Middle East.”

About isoSolutions Marketing & Management Inc.

Tags: